Effects of telmisartan, an angiotensin II receptor blocker, on vascular failure in hypertensive patients with chronic kidney disease

被引：0
|
作者：
Watanabe, Hideki [1 ]
Nakagawa, Kunio [1 ]
Kakihana, Masaaki [2 ]
机构：
[1] Kinu Med Assoc, Joso, Japan
[2] Tsukuba Mem Hosp, Tsukuba, Ibaraki, Japan
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2119
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [31] Nose response and pharmacokinetics of telmisartan, a new angiotensin II receptor blocker
    Neutel, JM
    Smith, DHG
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 : S210 - S210
  • [32] Effect of Angiotensin II Receptor Blocker on Cardiac Autonomic Activity in Patients with Chronic Heart Failure
    Ishikawa, Shohei
    Noma, Takahisa
    Matsunaga, Keiji
    Mantani, Kaoru
    Takabatake, Wataru
    Ishizawa, Makoto
    Ishikawa, Kaori
    Murakami, Kazushi
    Ohmori, Koji
    Kohno, Masakazu
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S172 - S172
  • [33] An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
    Kim-Mitsuyama, Shokei
    Ogawa, Hisao
    Matsui, Kunihiko
    Jinnouchi, Tomio
    Jinnouchi, Hideaki
    Arakawa, Kikuo
    [J]. KIDNEY INTERNATIONAL, 2013, 83 (01) : 167 - 176
  • [34] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [35] EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO BACKGROUND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER DOSE
    Heerspink, Hiddo Lambers
    Jong, Niels
    Stefansson, Bergur
    Chertow, Glenn
    Langkilde, Anna Maria
    Mcmurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Toto, Robert
    Wheeler, David
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I847 - I848
  • [36] Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
    Wu, Vin-Cent
    Lin, Yu-Feng
    Teng, Nai-Chi
    Yang, Shao-Yu
    Chou, Nai-Kuan
    Tsao, Chun-Hao
    Chen, Yung-Ming
    Chueh, Jeff S.
    Chen, Likwang
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure
    Nishio, Mayu
    Sakata, Yasushi
    Mano, Toshiaki
    Yoshida, Junichi
    Ohtani, Tomohito
    Takeda, Yasuharu
    Miwa, Takeshi
    Masuyama, Tohru
    Yamamoto, Kazuhiro
    Hori, Masatsugu
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (02) : 455 - 461
  • [38] Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure - The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators
    Dunselman, PHJM
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 77 (2-3) : 131 - 138
  • [39] Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease
    Guney, Ibrahim
    Selcuk, N. Yilmaz
    Altintepe, Lutfullah
    Atalay, Huseyin
    Basarali, M. Kemal
    Buyukbas, Sadik
    [J]. RENAL FAILURE, 2009, 31 (09) : 779 - 784
  • [40] Effects of combining an angiotensin-II receptor blocker and spironolactone on left ventricular remodeling in hypertensive patients
    Taniguchi, I
    Hashizume, Y
    Yamada, T
    Arino, T
    Kanae, K
    Shimizu, M
    Mochizuki, S
    [J]. CIRCULATION, 2003, 107 (19) : E164 - E164
12345